Further underscored by findings in human cancer cells, PI3K/AKT signaling sustains nuclear entry and DNA modulatory functions of SOX2, whereas in AKT-inhibited cells, SOX2 is retained in the cytosol and is successively cleared by proteasomal turnover [47,48,49,50]. This evidence concerns the gene SOX2 and cancer.